Cargando…
Development and validation of a platform reduced intact mass method for process monitoring of monoclonal antibody glycosylation during routine manufacturing
N-linked glycosylation is a primary source of heterogeneity associated with recombinant monoclonal antibodies and plays a key role in a myriad of drug properties associated with biological function. The glycosylation profile of recombinant monoclonal antibodies is influenced by an array of cell cult...
Autores principales: | Schilling, Michael, Feng, Pamela, Sosic, Zoran, Traviglia, Stacey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291849/ https://www.ncbi.nlm.nih.gov/pubmed/33201770 http://dx.doi.org/10.1080/21655979.2020.1842651 |
Ejemplares similares
-
Monoclonal antibody therapies for COVID-19: lessons learned
and implications for the development of future products()
por: Kelley, Brian, et al.
Publicado: (2022) -
In-Depth Method for the Characterization of Glycosylation
in Manufactured Recombinant Monoclonal Antibody Drugs
por: Song, Ting, et al.
Publicado: (2014) -
Charge variant native mass spectrometry benefits mass precision and dynamic range of monoclonal antibody intact mass analysis
por: Bailey, Aaron O., et al.
Publicado: (2018) -
N-Glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression
por: Dispenzieri, Angela, et al.
Publicado: (2020) -
Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
por: Kükrer, Başak, et al.
Publicado: (2010)